Switzerland has proposed a pilot project to study the financial and overall health impacts of non-health-related cannabis use, but any alter in the country’s laws to produce a sustainable adult-use cannabis business could be years away.

According to an amendment of Switzerland’s Narcotics Act presently prior to the country’s Parliament, the pilot project would enable up to five,000 individuals to use a wide variety of recreational cannabis goods.

The objective of the study is to collect scientific understanding on the use of non-health-related cannabis, like socioeconomic elements such as employment, household, public security and the illicit marketplace for drugs.

The legal basis for the scientific study, if it is authorized by Parliament, will be valid for up to 10 years.

The project would take into consideration a variety of goods, like cannabis flower, resin, oil and edibles, with THC content material restricted to a maximum of 20%.

The pilot lays out strict packaging specifications, mandating childproofing and overall health warnings. Advertising would be prohibited.

It also:

  • Prohibits the transmission of cannabis goods to third parties.
  • Limits the quantity of cannabis-primarily based goods a trial participant can obtain to no much more than they can consume in one particular month.
  • Suggests pharmacies and cannabis social clubs as possible points of sale.

Detailed details on the proposed pilot project can be identified right here (in French).

To sign up for our weekly international marijuana small business newsletter, click right here.

Categories: Briefs, Europe, International Marijuana Business enterprise News